Zhejiang Anglikang Pharmaceutical Hits Day High with 10% Surge

Zhejiang Anglikang Pharmaceutical Co. has experienced a significant uptick in its stock performance today, gaining 10.0% and reaching an intraday high of CNY 29.05. This surge stands in contrast to the broader market, as the China Shanghai Composite index only increased by 0.44% on the same day. Over the past week, Zhejiang Anglikang has shown a modest gain of 2.04%, while its performance over the last month reflects a decline of 15.48%. Despite this recent rebound, the stock has faced challenges over the past year, with a notable decrease of 28.83%, significantly underperforming the market's 18.93% gain. Financially, the company reported a net profit of CNY 76.67 million for the nine months ending March 26, marking a remarkable growth of 172.44%. The return on capital employed (ROCE) reached a high of 7.96%, and raw material costs have decreased by 1.33% year-over-year. With a price-to-book ratio of 3.37 and a return on equity of 9.35%, Zhejiang Anglikang maintains a fair valuation, complemented by a dividend yield of 0.82%.